The stock price of Opthea Limited ADR (NASDAQ: OPT) has jumped by 13.64 compared to previous close of 4.07. Despite this, the company has seen a gain of 18.89% in its stock price over the last five trading days. globenewswire.com reported 2024-09-30 that MELBOURNE, Australia and PRINCETON, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that management will participate in a fireside chat and be available for one-on-one investor meetings at the UBS Virtual Ophthalmology Day 2024 being held on October 2, 2024.
Is It Worth Investing in Opthea Limited ADR (NASDAQ: OPT) Right Now?
Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OPT is 82.85M and currently, short sellers hold a 0.08% of that float. On October 02, 2024, OPT’s average trading volume was 16.24K shares.
OPT’s Market Performance
The stock of Opthea Limited ADR (OPT) has seen a 18.89% increase in the past week, with a 49.89% rise in the past month, and a 142.65% gain in the past quarter. The volatility ratio for the week is 10.90%, and the volatility levels for the past 30 days are at 7.17% for OPT. The simple moving average for the past 20 days is 33.50% for OPT’s stock, with a 56.71% simple moving average for the past 200 days.
Analysts’ Opinion of OPT
Many brokerage firms have already submitted their reports for OPT stocks, with H.C. Wainwright repeating the rating for OPT by listing it as a “Buy.” The predicted price for OPT in the upcoming period, according to H.C. Wainwright is $14 based on the research report published on December 08, 2022 of the previous year 2022.
SVB Leerink, on the other hand, stated in their research note that they expect to see OPT reach a price target of $25. The rating they have provided for OPT stocks is “Outperform” according to the report published on April 26th, 2022.
Citigroup gave a rating of “Buy” to OPT, setting the target price at $48 in the report published on November 17th of the previous year.
OPT Trading at 61.57% from the 50-Day Moving Average
After a stumble in the market that brought OPT to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 5.11% of gains for the given period.
Volatility was left at 7.17%, however, over the last 30 days, the volatility rate increased by 10.90%, as shares surge +59.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +121.53% upper at present.
During the last 5 trading sessions, OPT rose by +19.02%, which changed the moving average for the period of 200-days by +76.05% in comparison to the 20-day moving average, which settled at $3.55. In addition, Opthea Limited ADR saw 56.78% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for OPT
Current profitability levels for the company are sitting at:
- -1539.98 for the present operating margin
- 0.17 for the gross margin
The net margin for Opthea Limited ADR stands at -1765.92. The total capital return value is set at -1.54. Equity return is now at value -3388.40, with -153.73 for asset returns.
Based on Opthea Limited ADR (OPT), the company’s capital structure generated 1.61 points at debt to capital in total, while cash flow to debt ratio is standing at -0.8. The debt to equity ratio resting at -2.65. The interest coverage ratio of the stock is -6.35.
Currently, EBITDA for the company is -192.58 million with net debt to EBITDA at -0.15. When we switch over and look at the enterprise to sales, we see a ratio of 6216.92. The receivables turnover for the company is 0.01for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.94.
Conclusion
To wrap up, the performance of Opthea Limited ADR (OPT) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
